Central infusion of the melanocortin receptor antagonist agouti-related peptide (AgRP(83-132)) prevents cachexia-related symptoms induced by radiation and colon-26 tumors in mice
- 1 March 2007
- Vol. 28 (3) , 636-642
- https://doi.org/10.1016/j.peptides.2006.11.021
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Cancer cachexiaQJM: An International Journal of Medicine, 2005
- Anatomy and regulation of the central melanocortin systemNature Neuroscience, 2005
- Central administration of peptide and small molecule MC4 receptor antagonists induce hyperphagia in mice and attenuate cytokine-induced anorexiaPeptides, 2005
- Clinical Spectrum of Obesity and Mutations in the Melanocortin 4 Receptor GeneNew England Journal of Medicine, 2003
- Anti-cachectic effect of ghrelin in nude mice bearing human melanoma cellsBiochemical and Biophysical Research Communications, 2003
- CachexiaAnnals of Internal Medicine, 2000
- Long-term orexigenic effects of AgRP-(83—132) involve mechanisms other than melanocortin receptor blockadeAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2000
- Brainstem Application of Melanocortin Receptor Ligands Produces Long-Lasting Effects on Feeding and Body WeightJournal of Neuroscience, 1998
- Central injection in rats of α-melanocyte-stimulating hormone analog: effects on food intake and brain FosRegulatory Peptides, 1998
- Prognostic effect of weight loss prior tochemotherapy in cancer patientsThe American Journal of Medicine, 1980